Study of Aveir leadless pacemaker in Japan
Part of Heart & circulation clinical trials.
This trial is for people who already have an Aveir leadless pacemaker and either were in a previous study or need to upgrade from a single-chamber to a dual-chamber system. It helps monitor the device's performance in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already have or need a specific type of Aveir leadless pacemaker (a tiny pacemaker placed directly in your heart).
- You might be eligible if you were in the earlier Aveir DR i2i study and now continue using the same device.
- You might be eligible if you already have a single-chamber Aveir pacemaker and need to add a second chamber for better heart coordination.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a small, leadless pacemaker that is placed directly in the heart to treat slow heart rhythms. It's designed for people who need a pacemaker for the bottom chambers of the heart.
This study tests a new approach that combines a leadless pacemaker with a device to close off a part of the heart (left atrial appendage) to reduce stroke risk in people with atrial fibrillation. It may help patients who need both a pacemaker and stroke prevention.
This study uses your medical records from Medicare to learn how the Aveir DR leadless pacemaker performs in everyday life after it’s implanted. It mainly helps researchers and doctors understand real-world outcomes and care needs.
This study is an observational registry for people who have or will receive an AVEIR leadless pacemaker. It collects information to help doctors understand how the device performs over time.
This study tracks the safety and performance of AVEIR VR LP and AVEIR AR LP leadless pacemakers in people who already have them or will get one. It helps doctors and researchers see how well these small heart devices work over time.
This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.
Hear when a new Leadless Pacemaker trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.